Innovative Technology ADRx leverages proprietary structure-based technology to target previously undruggable misfolded proteins in neurodegenerative diseases, positioning it as a cutting-edge biotech innovator with unique therapeutic approaches.
Niche Market Focus With a focus on difficult-to-treat neurodegenerative conditions such as tau, TDP-43, and alpha-synuclein, ADRx offers opportunities to collaborate with pharma companies seeking novel solutions in neurodegenerative disease pipelines.
Growth Potential Despite a small team of 2-10 employees and modest revenue between 1 million and 10 million dollars, ADRx has secured 12 million dollars in funding, indicating strong investor confidence and potential for accelerated growth.
Strategic Collaborations The company's work aligns well with major industry players like Biogen and Gilead Sciences, offering opportunities for strategic partnerships, joint research, or licensing agreements focused on neurodegenerative therapeutics.
Digital Presence Using modern tech stacks such as Google Cloud CDN and HTTP/3, ADRx maintains an innovative digital presence that can facilitate outreach to research partners and investors interested in cutting-edge biotech developments.
$10B
$10B
$10B
$10B
$10B
$10B
$1B$10B
$10B
$10B
$10BADRx, Inc. uses 8 technology products and services including Google Cloud CDN, Wix, Module Federation, and more. Explore ADRx, Inc.'s tech stack below.
| ADRx, Inc. Email Formats | Percentage |
| FLast@adrxpharma.com | 67% |
| First@adrxpharma.com | 22% |
| Last@adrxpharma.com | 7% |
| First.Last@adrxpharma.com | 4% |
Biotechnology ResearchCalifornia, United States2-10 Employees
Preclinical biotechnology company leveraging proprietary structure-based technology to develop small molecule disaggregators and inhibitors targeting previously undruggable misfolded proteins in neurodegenerative diseases. Our pipeline consists of tau, TDP-43 and alpha-synuclein programs.
Company Overview
Funding & FinancialsADRx, Inc. has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Oct 13, 2020 in the amount of $12M.
ADRx, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & FinancialsADRx, Inc. has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Oct 13, 2020 in the amount of $12M.
ADRx, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com